DFDA

Doxycycline

Treatment for Syphilis

Typical Dosage: 100 mg orally twice daily

Effectiveness
93%
Safety Score
70%
Clinical Trials
14
Participants
50K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
70
DangerousModerateSafe
Treatment Details
Dosage Range
100 mg orally twice daily
Time to Effect
1-2 weeks for serologic response
Treatment Duration
14-28 days
Evidence Quality
MODERATE
Number Needed to Treat (NNT)
2(Treat 2 patients to see 1 additional successful outcome)
Number Needed to Harm (NNH)
15(Treat 15 patients to see 1 additional serious adverse event)
Confidence Score
90%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$20
Monitoring:$200
Side Effect Mgmt:$35
Total Annual:$255
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
ICER
$12,000/QALY
QALYs Gained
2.2
Outcome-Based Costs
Cost per Responder
$283
Cost per Remission
$283
Prescription Access Economics
Annual Societal Loss per Patient
$395
Cost of prescription-only barriers (visits, time, admin, price premium)
Physician Visit Cost
$300/year
Time Cost
$60/year
Travel + wait time
Insurance Admin Cost
$20/year
Prior auth, claims
Rx Price
$30/year
Potential OTC Price
$15/year
Estimated if OTC available
Early Treatment Benefit
+0.10 QALYs
From faster OTC access
Risk Assessment
Misuse Risk
MODERATE
Missed Diagnosis Risk
HIGH
Requires Monitoring
Yes
Needs lab work/checkups
Doxycycline Outcomes

for Syphilis

Efficacy Outcomes
Overall Effectiveness
+93%
Response Rate
+90%
Remission Rate
+90%
Common Side Effects
Gastrointestinal upset (nausea, vomiting, diarrhea)
+15%
Photosensitivity
+8%
Vaginal candidiasis
+7%
Esophageal irritation/ulceration
+0.5%

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
9 active trials recruiting for Doxycycline in Syphilis

Daily Doxycycline for Early Syphillis

NCT06683638RECRUITINGPHASE2
View Study
15 participants
INTERVENTIONAL
Seattle, United States
Started: Mar 3, 2025

The Efficacy of Doxycycline Post Exposure Prophylaxis for Preventing STIs Among MSM in Bangkok, Thailand.

NCT07397403RECRUITINGPHASE4
View Study
400 participants
INTERVENTIONAL
Sathorn, Thailand
Started: Oct 6, 2025

Doxi-Rio: Study on the Use of Doxycycline to Prevent Sexually Transmitted Infections in Rio de Janeiro

NCT07500415RECRUITINGNA
View Study
200 participants
INTERVENTIONAL
Rio de Janeiro, Brazil
Started: Oct 28, 2025

A Clinical Study to Assess the Efficacy of Weekly Doxycycline Prophylaxis to Reduce Bacterial Sexually Transmitted Infections (STI) in Young African Women

NCT07884240NOT YET RECRUITINGPHASE3
View Study
580 participants
INTERVENTIONAL
Gaborone, Botswana +3 more
Started: Nov 30, 2026

Superiority of On-demand PrEP Versus PEP on Using Doxycycline for Preventing STI in MSM

NCT06188442ACTIVE NOT RECRUITINGPHASE4
View Study
300 participants
INTERVENTIONAL
Shatin, Hong Kong
Started: Mar 29, 2025

A Randomized Controlled Trial of Doxycycline Post Exposure Prophylaxis to Prevent Incident Bacterial STIs Among Women in the United States

NCT07704957NOT YET RECRUITINGPHASE4
View Study
519 participants
INTERVENTIONAL
Started: Jan 1, 2027

Comparisons of Treatment Responses of Early Syphilis to Benzathine Penicillin G With or Without Doxycycline

NCT06069141RECRUITINGNA
View Study
688 participants
INTERVENTIONAL
Hsinchu, Taiwan +8 more
Started: Jan 1, 2024

Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections

NCT06738407RECRUITINGPHASE4
View Study
760 participants
INTERVENTIONAL
Los Angeles, United States +12 more
Started: Feb 27, 2026

Periodic Presumptive Treatment vs. doxyPEP for STI Control in Kenyan MSM

NCT06468462ACTIVE NOT RECRUITINGPHASE4
View Study
2.9K participants
INTERVENTIONAL
Kisumu, Kenya +2 more
Started: Oct 29, 2025
Completed Clinical Trials
7 completed trials for Doxycycline in Syphilis

Clinical Trial of Doxycycline VS BPG for Early Syphilis (SY-DOXY)

NCT04838717COMPLETEDPHASE3
View Study
200 participants
INTERVENTIONAL
Besançon, France +6 more
Started: Dec 6, 2021

Azithromycin/Bicillin Syphilis

NCT00031499COMPLETEDPHASE3
View Study
593 participants
INTERVENTIONAL
Birmingham, United States +9 more
Started: Jun 1, 2000

Oral Doxycycline for the Prevention of Syphilis in Men Who Have Sex with Men (DaDHS)

NCT02864550COMPLETEDPHASE4
View Study
52 participants
INTERVENTIONAL
Vancouver, Canada
Started: Aug 15, 2019

Evaluation of Doxycycline Post-exposure Prophylaxis to Reduce Sexually Transmitted Infections in PrEP Users and HIV-infected Men Who Have Sex With Men

NCT03980223COMPLETEDPHASE4
View Study
641 participants
INTERVENTIONAL
San Francisco, United States +2 more
Started: Nov 26, 2019

Efficacy of Doxycycline Prophylaxis to Reduce Syphilis in High-Risk, HIV-Positive MSM

NCT02257658COMPLETEDNA
View Study
30 participants
INTERVENTIONAL
Started: Sep 1, 2011

Tenofovir/Emtricitabine With Doxycycline for Combination HIV and Syphilis Pre-exposure Prophylaxis in HIV-negative MSM

NCT02844634COMPLETEDPHASE4
View Study
52 participants
INTERVENTIONAL
Vancouver, Canada
Started: May 15, 2018

Doxycycline PEP for Prevention of Sexually Transmitted Infections Among Kenyan Women Using HIV PrEP

NCT04050540COMPLETEDPHASE4
View Study
449 participants
INTERVENTIONAL
Kisumu, Kenya
Started: Feb 5, 2020